Literature DB >> 11063838

Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction.

J J Hallett1, C J Harling-Berg, P M Knopf, E G Stopa, L S Kiessling.   

Abstract

Serologic studies of children with Tourette syndrome (TS) have detected anti-neuronal antibodies but their role in TS has not been explored. Stereotypies and episodic utterances, analogous to involuntary movements seen in TS, were induced in rats by intrastriatal microinfusion of TS sera or gamma immunoglobulins (IgG) under noninflammatory conditions, as found in TS. Immunohistochemical analysis confirmed the presence of IgG selectively bound to striatal neurons. These data support the hypothesis that binding of an anti-neuronal antibody from some children with TS induced striatal dysfunction and suggest a possible cause for the basal ganglia alterations observed in children with TS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063838     DOI: 10.1016/s0165-5728(00)00320-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  29 in total

1.  Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors:  A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

2.  Anti-streptococcus IgM antibodies induce repetitive stereotyped movements: cell activation and co-localization with Fcα/μ receptors in the striatum and motor cortex.

Authors:  Danhui Zhang; Ankur Patel; Youhua Zhu; Allan Siegel; Steven S Zalcman
Journal:  Brain Behav Immun       Date:  2012-01-21       Impact factor: 7.217

3.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

Authors:  Lior Brimberg; Itai Benhar; Adita Mascaro-Blanco; Kathy Alvarez; Dafna Lotan; Christine Winter; Julia Klein; Allon E Moses; Finn E Somnier; James F Leckman; Susan E Swedo; Madeleine W Cunningham; Daphna Joel
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

Review 4.  Tourette syndrome and obsessive-compulsive disorder.

Authors:  Paul J Lombroso; Lawrence Scahill
Journal:  Brain Dev       Date:  2007-10-15       Impact factor: 1.961

5.  Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.

Authors:  Dafna Lotan; Itai Benhar; Kathy Alvarez; Adita Mascaro-Blanco; Lior Brimberg; Dan Frenkel; Madeleine W Cunningham; Daphna Joel
Journal:  Brain Behav Immun       Date:  2014-02-20       Impact factor: 7.217

6.  How relevant are GFAP autoantibodies in autism and Tourette Syndrome?

Authors:  Nikki J Kirkman; Jane E Libbey; Thayne L Sweeten; Hilary H Coon; Judith N Miller; Edward K Stevenson; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2007-06-20

7.  Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.

Authors:  Neal R Swerdlow; Michele J Bongiovanni; Laura Tochen; Jody M Shoemaker
Journal:  Psychopharmacology (Berl)       Date:  2006-04-01       Impact factor: 4.530

8.  Neuroimmune aspects of the pathogenesis of Tourette's syndrome and experience in the use of immunoglobulins in children.

Authors:  V P Zykov; A Yu Shcherbina; E B Novikova; T V Shvabrina
Journal:  Neurosci Behav Physiol       Date:  2009-09

Review 9.  Immunopathogenic mechanisms in tourette syndrome: A critical review.

Authors:  Davide Martino; Russell C Dale; Donald L Gilbert; Gavin Giovannoni; James F Leckman
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 10.  Immune-mediated animal models of Tourette syndrome.

Authors:  Mady Hornig; W Ian Lipkin
Journal:  Neurosci Biobehav Rev       Date:  2013-01-10       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.